Skip to content

Welcome VHypotenuse as a corporate member

Date: July 1, 2025

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as a new corporate member.

Founded in 2021, VHypotenuse was born from a deep-rooted passion for science and technology, driven by a strong desire to make a meaningful impact on the world. Originally established as an IT and Data Management company, VHypotenuse has since expanded into the field of Clinical Research, conducting clinical trials across a range of therapeutic areas. At VHypotenuse, they are committed to delivering innovative and reliable solutions to our clients.

VHypotenuse joined the ACDM as part of its ongoing commitment to upholding the highest standards in clinical research and data integrity. The association offers a valuable platform for collaboration, learning, and contributing to best practices, supporting VHypotenuse’s mission to enhance quality, efficiency, and compliance in clinical trials while advancing patient safety and scientific rigour.

Members gain many benefits from membership, including:

  • Access to training courses at a discounted rate
  • Assign full ACDM membership to all individuals within your organisation
  • Place an organisation profile, description and logo on the ACDM website
  • Advertise jobs for your positions within your organisation
  • Reduced price attendance at conferences and symposia
  • Free attendance at Hot Topics

Find out more about becoming a corporate member here.

 


 

Explore More News

Welcome Climedo as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Climedo as a . . .

Read More

Clinical Trials for Medicines – New Notification Scheme

The MHRA have recently launched a new notification scheme, the first step in their . . .

Read More

EMA Management Board: Highlights of October 2023 meeting

The EMA’s Management Board met on 5 October in Amsterdam. The article below covers the . . .

Read More

Welcome Mednet as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Mednet as a new . . .

Read More

Welcome Allucent as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a . . .

Read More

Welcome KCR as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .

Read More

Welcome Debiopharm as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .

Read More

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025

The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .

Read More

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3

As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .

Read More

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines

The EMA has opened a public consultation on a reflection paper presenting views . . .

Read More

Welcome Instem as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .

Read More

Regulatory Considerations Expert Group reviews draft FDA Guidance

The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .

Read More